Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries

This publication has 16 references indexed in Scilit:

• The impact of landmark clinical trials on secondary prevention of acute myocardial infarction (AMI) in Spain. Prevese 98 study
  Atherosclerosis, 2000
• A Clinical Practice Guideline for Treating Tobacco Use and Dependence: A US Public Health Service Report
  JAMA, 2000
• Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe
  Published by Oxford University Press (OUP) ,2000
• Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report
  Published by Oxford University Press (OUP) ,2000
• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
  New England Journal of Medicine, 2000
• Impact of smoking cessation and smoking interventions in patients with coronary heart disease
  European Heart Journal, 1999
• After 4S, CARE and LIPID — is evidence-based medicine being practised?
  Atherosclerosis, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
  European Heart Journal, 1998
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996